NAUTILUS BIOTECHNOLOGY INC. - COMMON STOCK
1.5600
21-February-25 12:30:51
15 minutes delayed
Stocks
-0.0400
-2.50%
Today's range
1.5500 - 1.6500
ISIN
N/A
Source
NASDAQ
-
Nautilus Biotechnology Reports Second Quarter 2022 Financial Results
02 Aug 2022 06:48:06 By Nasdaq GlobeNewswire
-
01 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
13 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology Reports First Quarter 2022 Financial Results
03 May 2022 06:00:00 By Nasdaq GlobeNewswire
-
12 Apr 2022 08:00:03 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
07 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology to Present at EuPA and AACR Meetings
04 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors
31 Mar 2022 16:05:01 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results
24 Feb 2022 06:00:00 By Nasdaq GlobeNewswire
-
Nautilus to Participate in the 42nd Annual Cowen Health Care Conference
16 Feb 2022 16:05:00 By Nasdaq GlobeNewswire
-
27 Jan 2022 08:00:00 By Nasdaq GlobeNewswire
-
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
02 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology Reports Third Quarter 2021 Financial Results
02 Nov 2021 06:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2021 08:00:00 By Nasdaq GlobeNewswire
-
Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
03 Sep 2021 09:00:00 By Nasdaq GlobeNewswire
-
Nautilus Biotechnology Reports Second Quarter 2021 Financial Results
10 Aug 2021 06:00:00 By Nasdaq GlobeNewswire